Drug Type Small molecule drug |
Synonyms FHT 185, FHT185 |
Target |
Action inhibitors |
Mechanism SMARCA2 inhibitors(Probable global transcription activator SNF2L2 inhibitors), SMARCA4 inhibitors(Transcription activator BRG1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC20H20N4O4S2 |
InChIKeyFNJDMRMVWHPFCX-UHFFFAOYSA-N |
CAS Registry878254-76-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Discovery | United States | 30 Apr 2021 |